Aleksandra Rachitskaya, MD
Retina Specialist · Cleveland, OHNPI 1487802757
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $205,439 of the $303,177 with a category attached, or 67.8%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.5%. Among retina specialist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $1436.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$53K
- Apellis Pharmaceuticals, Inc.$48K
- Boehringer Ingelheim International GmbH$35K
- Regeneron Healthcare Solutions, Inc.$22K
- Alcon Research LLC$20K
- Novartis$19K
- plus $106K from 15 others
Across 120 payments — averaging $15,385 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Apellis Pharmaceuticals, Inc.$886K
- Genentech, Inc.$740K
- Novartis$168K
- Cortigent Inc$27K
- F. Hoffmann-la Roche AG$16K
- Regeneron$11K
What the payments were for
- Consulting fees$205,43968%
- Speaking & faculty fees$63,24221%
- Travel & lodging$27,0309%
- Food & beverage$6,8472%
- Education$6190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 43 | $53,015 |
| Apellis Pharmaceuticals, Inc. | 23 | $47,555 |
| Boehringer Ingelheim International GmbH | 8 | $34,939 |
| Regeneron Healthcare Solutions, Inc. | 16 | $22,146 |
| Alcon Research LLC | 11 | $20,426 |
| Novartis | 11 | $19,000 |
| Astellas Pharma US Inc | 8 | $15,909 |
| F. Hoffmann-la Roche AG | 6 | $15,588 |
| Ocular Therapeutix, Inc. | 12 | $15,575 |
| Carl Zeiss Meditec, Inc. | 11 | $13,670 |
| Genentech USA, Inc. | 10 | $13,156 |
| AbbVie(2 entities) | 19 | $10,777 |
| Regeneron | 11 | $7,365 |
| Eyepoint US, Inc. | 7 | $3,784 |
| Roche Products Limited | 3 | $3,197 |
| Genentech, Inc. | 3 | $2,497 |
| Samsara Vision | 2 | $2,424 |
| Alimera Sciences, Inc. | 4 | $1,304 |
| Bausch & Lomb Americas Inc. | 1 | $825 |
| Celltrion USA Inc. | 1 | $16 |
| Cortigent Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$31,609
- EYLEA$21,926
- Syfovre$18,447
- SUSVIMO$16,920
- BEOVU$16,230
- Izervay$13,800
- VABYSMO$11,275
- CIRRUS HD-OCT$10,850
- OZURDEX$9,807
- EYLEA HD$7,652
- Retina Workplace$6,475
- CLARUS 500$5,500
- FORUM$3,775
- EYP-1901$3,491
- Unity$3,407
- CLARUS$3,300
- Glaucoma Workplace$3,300
- Humphrey HFA$3,300
- NGENUITY$3,292
- Lucentis$2,545
How this compares
$303,177 in reported general payments places this provider in the 95th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Difluprednate | 36 | $3,963 |
| Prednisolone Acetate | 108 | $3,636 |
| Brinzolamide | 13 | $1,825 |
| Latanoprost | 49 | $1,002 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 48 | $706 |
| Atropine Sulfate | 23 | $576 |
| Ketorolac Tromethamine | 30 | $471 |
| Ciprofloxacin Hcl | 37 | $361 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 22 | $227 |
| Brimonidine Tartrate | 21 | $103 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Cleveland
- Sumit SharmaCleveland$428K
- Katherine TalcottCleveland$272K
- Suber HuangCleveland$124K
- Ananth SastryCleveland$44K
- Phoebe LinCleveland$22K
- Warren SobolCleveland$5K
- Mark SeralyCleveland$3K
- Abhishek NaiduCleveland$3K
- Mary-Grace ReevesCleveland$2K
- Joseph ConeyBeachwood$980K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.